/IINN
IINN Stock - Inspira Technologies Oxy B.H.N. Ltd.
Healthcare|Medical - DevicesNASDAQ
$1.02-0.49%
$0.01 (-0.49%) • Dec 19
54
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.55
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.30
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $1.12
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for IINN
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1.01 – $1.03
TARGET (TP)$1.17
STOP LOSS$0.94
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta2.25
52W High$1.65
52W Low$0.40
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | $-4,678,000 | N/A | N/A |
| Gross Profit | $-488,000 | $-406,000 | $-5,039,000 | $-218,000 | $-203,000 |
| Gross Margin | N/A | N/A | 107.7% | N/A | N/A |
| Operating Income | $11,267 | $-12,133,000 | $14.89M | $-12,167,000 | $-6,269,000 |
| Net Income | $-11,053 | $-11,286,000 | $-4,002,000 | $-16,961,000 | $-7,233,000 |
| Net Margin | N/A | N/A | 85.5% | N/A | N/A |
| EPS | $-0.00 | $-0.93 | $-1.39 | $-3.20 | $-1.01 |
Company Overview
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. The company was incorporated in 2018 and is based in Ra'annana, Israel.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
IINNBeat Rate
100%
Last 6 quarters
Avg Surprise
+47.2%
EPS vs Estimate
Beats / Misses
6/0
Last 12 quarters
Latest EPS
$-0.12
Q4 2025
EPS Surprise History
Q3 22
No data
Q4 22
No data
Q1 23
No data
Q2 23
+91.7%
$-0.03vs$-0.36
Q3 23
+26.4%
$-0.24vs$-0.32
Q4 23
+26.7%
$-0.22vs$-0.30
Q1 24
+41.4%
$-0.17vs$-0.29
Q4 25
+45.7%
$-0.12vs$-0.22
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Mar 11, 2026 | — | — | — | — |
Q4 2025 | Oct 1, 2025 | $-0.22 | $-0.12 | +45.7% | ✓ BEAT |
Q2 2025 | Jun 30, 2025 | — | — | — | — |
Q1 2025 | Mar 24, 2025 | — | — | — | — |
Q1 2025 | Mar 10, 2025 | $-0.16 | — | — | — |
Q3 2024 | Aug 15, 2024 | $-0.54 | — | — | — |
Q2 2024 | Apr 8, 2024 | — | — | — | — |
Q1 2024 | Mar 25, 2024 | $-0.29 | $-0.17 | +41.4% | ✓ BEAT |
Q4 2023 | Nov 16, 2023 | $-0.30 | $-0.22 | +26.7% | ✓ BEAT |
Q3 2023 | Aug 10, 2023 | $-0.32 | $-0.24 | +26.4% | ✓ BEAT |
Q2 2023 | Apr 4, 2023 | $-0.36 | $-0.03 | +91.7% | ✓ BEAT |
Q1 2023 | Mar 30, 2023 | — | $-0.28 | — | — |
Q4 2022 | Nov 23, 2022 | — | $-0.33 | — | — |
Q3 2022 | Aug 11, 2022 | — | $0.23 | — | — |
Q2 2022 | May 19, 2022 | — | $0.28 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-1.02 | — | — |
Q4 2021 | Nov 23, 2021 | — | $0.29 | — | — |
Q3 2021 | Aug 13, 2021 | $-1.15 | $-0.56 | +51.6% | ✓ BEAT |
Q2 2021 | Jun 30, 2021 | — | $-0.13 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.25 | — | — |
Latest News
Inspira Announces $1.8M Registered Direct Offering Of 1,565,217 Shares At $1.15/Share
➖ NeutralBenzinga•Dec 15, 2025, 01:38 PM
Inspira Technologies Announces Strategic Expansion Of Core Blood Laboratory Capabilities For Accelerated Future Growth
📈 PositiveBenzinga•Dec 3, 2025, 01:45 PM
Inspira Technologies Completes Clinical Trial For Its HYLA Blood Sensor Toward Regulatory Submission, Future Commercialization
📈 PositiveBenzinga•Nov 13, 2025, 02:03 PM
Inspira Technologies shares are trading higher after the company announced that it has completed the regulatory submission of its FDA-cleared INSPIRA ART100 system to the United Arab Emirates Ministry of Health and Prevention.
📈 PositiveBenzinga•Nov 6, 2025, 03:30 PM
Inspira Technologies Completes Regulatory Requirement Of Its INSPIRA ART100 System To UAE Ministry Of Health And Prevention
📈 PositiveBenzinga•Nov 6, 2025, 02:14 PM
Inspira Technologies Collaborates With Bites Learning To Transform Training, Accelerate Onboarding, And Enhance Operational Performance For Users Worldwide
📈 PositiveBenzinga•Oct 22, 2025, 12:32 PM
Inspira Technologies To Present HYLA Blood Sensor To Global Medical Community At U.S. ELSO Annual Conference 2025
📈 PositiveBenzinga•Sep 18, 2025, 12:14 PM
Inspira Technologies OXY B.H.N To Increase Maximum Offering Price Of Ordinary Shares Under Sales Agreement From $7.1M To About $10M
📈 PositiveBenzinga•Sep 16, 2025, 09:08 PM
Inspira Technologies Reports Pivotal Results For HYLA Blood Sensor, Achieving 97.35% Accuracy In Latest Performance Testing Phase That Will Support Upcoming FDA Submission
📈 PositiveBenzinga•Sep 11, 2025, 01:32 PM
Inspira Technologies Says A U.S. Hospital Expands Clinical Use Of INSPIRA ART100 System To Lung Transplantation Procedures
📈 PositiveBenzinga•Sep 2, 2025, 01:07 PM
Inspira shares are trading higher after the company received U.S. patent approval for its ART500 core technology.
📈 PositiveBenzinga•Aug 22, 2025, 12:46 PM
Inspira Technologies Receives U.S. Patent Approval For Low Flow Rates Extracorporeal Oxygenation System And Methods Of Use
📈 PositiveBenzinga•Aug 22, 2025, 12:46 PM
Inspira Technologies secures $27M order from African Ministry of Health; shares up
📈 PositiveSeeking Alpha•Aug 19, 2025, 12:48 PM
Inspira Technologies Says National Ministry Of Health In Africa Places $27M Binding Purchase Order For Inspira's FDA-Cleared ART100 Systems
📈 PositiveBenzinga•Aug 19, 2025, 12:40 PM
Inspira Receives $27M Binding Purchase Order From A Health Ministry In Africa For ART100 Systems, Full Payment Expected In 2025
📈 PositiveBenzinga•Aug 19, 2025, 12:31 PM
Inspira Technologies secures $22.5 million purchase order
📈 PositiveSeeking Alpha•Jul 2, 2025, 01:57 PM
Inspira stock soars on initiating global commercial rollout of ART100 system
📈 PositiveSeeking Alpha•May 29, 2025, 03:18 PM
Frequently Asked Questions about IINN
What is IINN's current stock price?
Inspira Technologies Oxy B.H.N. Ltd. (IINN) is currently trading at $1.02 per share. The stock has moved -0.49% today.
What is the analyst price target for IINN?
No analyst price targets are currently available for this stock.
What sector is Inspira Technologies Oxy B.H.N. Ltd. in?
Inspira Technologies Oxy B.H.N. Ltd. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NASDAQ exchange.
What is IINN's market cap?
Inspira Technologies Oxy B.H.N. Ltd. has a market capitalization of $0.02 billion, making it a small-cap company.
Does IINN pay dividends?
No, Inspira Technologies Oxy B.H.N. Ltd. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCOSM
Cosmos Health Inc.
$0.49
Mkt Cap: $0.0B
ENLV
Enlivex Therapeutics Ltd.
$0.83
Mkt Cap: $0.0B
FEMY
Femasys Inc.
$0.86
Mkt Cap: $0.0B
IRIX
IRIDEX Corporation
$1.00
Mkt Cap: $0.0B
LSTA
Lisata Therapeutics, Inc.
$2.06
Mkt Cap: $0.0B
MTVA
MetaVia Inc.
$8.62
Mkt Cap: $0.0B
NXGL
NEXGEL, Inc.
$1.62
Mkt Cap: $0.0B
NXL
Nexalin Technology, Inc.
$0.83
Mkt Cap: $0.0B
PASG
Passage Bio, Inc.
$9.59
Mkt Cap: $0.0B
PTHS
Pelthos Therapeutics Inc.
$25.63
Mkt Cap: $0.0B
Explore stocks similar to IINN for comparison